Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole P Børmer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Immunological Methods|December 9, 2003
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2Elisabeth Paus, Hilde Almåsbak, Ole P Børmer, et al.
Clinical Biochemistry|April 12, 2005
Human heterophilic antibodies display specificity for murine IgG subclassesJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Testing and validating a homogeneous immunometric assay for interferenceJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Chemistry|February 19, 2005
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodiesDavid J Warren, Johan Bjerner, Elisabeth Paus, et al.
BMC Clinical Pharmacology|March 30, 2004
Pharmaceutical-grade albumin: impaired drug-binding capacity in vitroHarald Olsen, Anders Andersen, Arve Nordbø, et al.
Clinical Chemistry|March 20, 2002
Immunometric assay interference: incidence and preventionJohan Bjerner, Kjell Nustad, Lars F Norum, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|December 9, 2003
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2Elisabeth Paus, Hilde Almåsbak, Ole P Børmer, et al.
Clinical Biochemistry|April 12, 2005
Human heterophilic antibodies display specificity for murine IgG subclassesJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Testing and validating a homogeneous immunometric assay for interferenceJohan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Chemistry|February 19, 2005
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodiesDavid J Warren, Johan Bjerner, Elisabeth Paus, et al.
BMC Clinical Pharmacology|March 30, 2004
Pharmaceutical-grade albumin: impaired drug-binding capacity in vitroHarald Olsen, Anders Andersen, Arve Nordbø, et al.
Clinical Chemistry|March 20, 2002
Immunometric assay interference: incidence and preventionJohan Bjerner, Kjell Nustad, Lars F Norum, et al.
Pageof 1